a leading provider of data observability and agentic data management solutions, today debuted its Agentic Data Management Platform at Autonomous 25, the premier conference uniting data leaders and ...

At ASCO 2025, CCM Biosciences’ presentation "Novel, Potent and Selective Inhibitors Targeting FLT3 for AML Therapy" in the Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes ...

CAMPBELL, Calif., May 20, 2025 (GLOBE NEWSWIRE) -- Acceldata, a leading provider of data observability and agentic data management solutions, today debuted its Agentic Data Management Platform at ...

Showcase your company news with guaranteed exposure both in print and online Join us for an illuminating exploration of New Mexico's energy landscape at this years… Outstanding Women in Business ...

Skills taught include relational database design and management, object-oriented computer programming, web server technology, forecasting, large-scale statistical analysis, data mining, decision ...

EMD Serono, the Healthcare business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, today announced the presentation of new oncology data across more than 12 tumor types at the 2025 ...

Company’s NSCLC drug program is focused on overcoming both mutational and non-mutational resistance to 3 rd-generation EGFR inhibitors and outperforms other investigational 4 th-generation inhibitors ...

MOUNT LAUREL, N.J.--(BUSINESS WIRE)-- CCM Biosciences, a diversified pharmaceutical discovery and development company, today announced the upcoming presentation of its 4th-generation EGFR inhibitor ...